E
Altamira Therapeutics Ltd. CYTOF
$0.10 $0.0223.63% OTC PK
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -30.26% -37.20% -42.27% 58.04% 82.76%
Total Depreciation and Amortization 136.51% 114.58% 94.19% -3.79% -52.57%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 17.92% 69.88% 100.42% -81.36% -95.69%
Change in Net Operating Assets 5.72% 115.16% 100.78% 108.95% 127.69%
Cash from Operations -34.03% 10.55% 27.49% 54.06% 72.69%
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -100.00% 0.00% -- -- --
Other Investing Activities -2,300.00% -3,275.00% -6,200.00% 98.30% 100.09%
Cash from Investing -19,500.00% -29,075.00% -57,800.00% 83.15% 100.09%
Total Debt Issued -- -84.01% -- -- --
Total Debt Repaid -75.34% -8.40% 19.98% 48.91% 68.95%
Issuance of Common Stock 78.83% 39.58% 22.35% -32.18% -69.10%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -1,106.38% -491.86% -301.21% -89.17% 75.58%
Cash from Financing 73.31% -0.59% -22.68% -55.94% -78.91%
Foreign Exchange rate Adjustments -220.79% -146.61% -120.14% -88.69% -71.27%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 88.60% 130.00% 582.99% 2.66% -71.11%